Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.


Journal

FEBS letters
ISSN: 1873-3468
Titre abrégé: FEBS Lett
Pays: England
ID NLM: 0155157

Informations de publication

Date de publication:
03 2020
Historique:
received: 02 08 2019
revised: 21 10 2019
accepted: 23 10 2019
pubmed: 14 11 2019
medline: 6 10 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

The constituent paired helical filaments (PHFs) in neurofibrillary tangles are insoluble intracellular deposits central to the development of Alzheimer's disease (AD) and other tauopathies. Full-length tau requires the addition of anionic cofactors such as heparin to enhance assembly. We have shown that a fragment from the proteolytically stable core of the PHF, tau 297-391 known as 'dGAE', spontaneously forms cross-β-containing PHFs and straight filaments under physiological conditions. Here, we have analysed and compared the structures of the filaments formed by dGAE in vitro with those deposited in the brains of individuals diagnosed with AD. We show that dGAE forms PHFs that share a macromolecular structure similar to those found in brain tissue. Thus, dGAEs may serve as a model system for studying core domain assembly and for screening for inhibitors of tau aggregation.

Identifiants

pubmed: 31721178
doi: 10.1002/1873-3468.13675
pmc: PMC7078754
doi:

Substances chimiques

MAPT protein, human 0
tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

944-950

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S003312/1
Pays : United Kingdom

Informations de copyright

© 2019 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

FEBS Lett. 2004 Jun 18;568(1-3):178-82
pubmed: 15196943
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9034-8
pubmed: 12853572
J Mol Biol. 2017 Nov 24;429(23):3650-3665
pubmed: 28919235
Biomolecules. 2016 Jan 07;6(1):9
pubmed: 26751496
Am J Pathol. 1997 Jun;150(6):2181-95
pubmed: 9176408
Nat Rev Neurosci. 2007 Sep;8(9):663-72
pubmed: 17684513
Methods Mol Biol. 2019;1873:109-122
pubmed: 30341606
Chem Commun (Camb). 2018 May 1;54(36):4573-4576
pubmed: 29664486
EMBO J. 1989 Feb;8(2):393-9
pubmed: 2498079
Proc Natl Acad Sci U S A. 1988 Jun;85(12):4506-10
pubmed: 3132715
EMBO J. 1993 Jan;12(1):365-70
pubmed: 7679073
J Biol Chem. 2015 Apr 24;290(17):10862-75
pubmed: 25759392
Nature. 2019 Apr;568(7752):420-423
pubmed: 30894745
Nature. 1996 Oct 10;383(6600):550-3
pubmed: 8849730
Nature. 2018 Sep;561(7721):137-140
pubmed: 30158706
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
J Neurochem. 1996 Sep;67(3):1183-90
pubmed: 8752125
Acta Neuropathol. 1995;89(1):50-6
pubmed: 7709731
FEBS Lett. 1996 Dec 16;399(3):344-9
pubmed: 8985176
Elife. 2019 Feb 05;8:
pubmed: 30720432
Acta Neuropathol Commun. 2019 Mar 1;7(1):31
pubmed: 30823892
J Cell Biol. 1985 Jun;100(6):1905-12
pubmed: 2581978
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5837-41
pubmed: 1712107
Biochemistry. 2004 Feb 17;43(6):1694-703
pubmed: 14769047
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5842-6
pubmed: 1905817
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11213-8
pubmed: 8855335
Ann Med. 1989;21(2):127-32
pubmed: 2504257

Auteurs

Youssra K Al-Hilaly (YK)

Dementia Research Group, Sussex Neuroscience, School of Life Sciences, University of Sussex, E Sussex, UK.
Chemistry Department, College of Science, Mustansiriyah University, Baghdad, Iraq.

Bronwen E Foster (BE)

Dementia Research Group, Sussex Neuroscience, School of Life Sciences, University of Sussex, E Sussex, UK.

Luca Biasetti (L)

Dementia Research Group, Sussex Neuroscience, School of Life Sciences, University of Sussex, E Sussex, UK.

Liisa Lutter (L)

School of Biosciences, University of Kent, Canterbury, UK.

Saskia J Pollack (SJ)

Dementia Research Group, Sussex Neuroscience, School of Life Sciences, University of Sussex, E Sussex, UK.

Janet E Rickard (JE)

Institute of Medical Sciences, University of Aberdeen, UK.

John M D Storey (JMD)

Department of Chemistry, University of Aberdeen, UK.
TauRx Therapeutics Ltd., Aberdeen, UK.

Charles R Harrington (CR)

Institute of Medical Sciences, University of Aberdeen, UK.
TauRx Therapeutics Ltd., Aberdeen, UK.

Wei-Feng Xue (WF)

School of Biosciences, University of Kent, Canterbury, UK.

Claude M Wischik (CM)

Institute of Medical Sciences, University of Aberdeen, UK.
TauRx Therapeutics Ltd., Aberdeen, UK.

Louise C Serpell (LC)

Dementia Research Group, Sussex Neuroscience, School of Life Sciences, University of Sussex, E Sussex, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH